These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2568577)

  • 1. Carteolol and penbutolol for hypertension.
    Med Lett Drugs Ther; 1989 Jul; 31(797):70-1. PubMed ID: 2568577
    [No Abstract]   [Full Text] [Related]  

  • 2. Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.
    Frishman WH; Covey S
    J Clin Pharmacol; 1990 May; 30(5):412-21. PubMed ID: 2189902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penbutolol in hypertension: evaluation of a new beta-adrenergic blocking drug.
    Bett JH; Wilkinson RK; Williams J; Ryan H
    Med J Aust; 1980 Jan; 1(1):30-1. PubMed ID: 6987484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
    Werning C
    Arzneimittelforschung; 1983; 33(2a):325-30. PubMed ID: 6682324
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension.
    Graml E; Verho M; Rangoonwala B; Englert R; Häringer E; Pahnke K
    Pharmatherapeutica; 1985; 4(4):236-43. PubMed ID: 3903788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of penbutolol (HOE 893 d), a non-selective beta blocker, in the control of essential arterial hypertension].
    Calle Pascual AL; Charro Salgado AL
    Med Clin (Barc); 1983 Feb; 80(5):201-3. PubMed ID: 6855302
    [No Abstract]   [Full Text] [Related]  

  • 7. Penbutolol in hypertension, alone and in combination with furosemide. A long-term multicentre study.
    Vander Elst E; Lawrence J; Rössner M; Mertens H
    S Afr Med J; 1983 Jan; 63(5):143-7. PubMed ID: 6336854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penbutolol in hypertension--single daily doses versus divided dosage schedule.
    Yajnik VH; Nandi JS; Karvadia SV
    J Assoc Physicians India; 1982 Feb; 30(2):85-8. PubMed ID: 6763031
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids].
    Ocón J; Piña C; Castellet R; Vila R; del Río G; Arnau C
    Med Clin (Barc); 1985 Jun; 85(2):53-7. PubMed ID: 3894828
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study].
    Rosprich G; Sölter H
    Arzneimittelforschung; 1983; 33(2a):334-9. PubMed ID: 6682326
    [No Abstract]   [Full Text] [Related]  

  • 11. [Penbutolol and propranolol in the treatment of hypertension. A double-blind comparative study in general practice].
    Astvad K; Krogh A; Sidenius J
    Ugeskr Laeger; 1984 Oct; 146(41):3104-6. PubMed ID: 6393504
    [No Abstract]   [Full Text] [Related]  

  • 12. Penbutolol or hydrochlorothiazide once a day in hypertension. A controlled study with home measurements.
    De Plaen JF; Vander Elst E; Van Ypersele de Strihou C
    Br J Clin Pharmacol; 1981 Aug; 12(2):215-21. PubMed ID: 7030372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-blind comparison of penbutolol and long-acting propranolol in general practice.
    Hayes G
    Pharmatherapeutica; 1983; 3(7):456-63. PubMed ID: 6366804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carteolol treatment of essential hypertension: a long-term study of safety and efficacy.
    Luther RR; Maurath CJ; Klepper MJ; Peckinpaugh RO; Ringham GL
    J Int Med Res; 1986; 14(4):175-84. PubMed ID: 3758467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
    Lameijer LD; Voermans LA; Houtzagers JJ; Chadha DR
    Eur J Clin Pharmacol; 1981; 21(2):93-6. PubMed ID: 7042370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.
    Tarkiainen A; Saraste K; Seppälä T; Gordin A; Auvinen J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):239-44. PubMed ID: 6116605
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of penbutolol (Hoe, 893 d) (beta adrenergic blockader), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. I: Effect on arterial hypertension. Comparative study of 2 parallel groups with crossed sequences by the simple-blind method].
    Ocón J; Piña C; del Río G
    Med Clin (Barc); 1985 Jun; 85(1):13-6. PubMed ID: 4021602
    [No Abstract]   [Full Text] [Related]  

  • 18. Penbutolol in black hypertensive patients.
    Venter CP; Joubert PH
    S Afr Med J; 1986 Mar; 69(5):286-7. PubMed ID: 3515587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of essential mild-to-moderate arterial hypertension with once-daily penbutolol. Controlled clinical study vs atenolol].
    Nami R; Martinelli M; Bianchini C; Gennari C
    Minerva Med; 1988 Nov; 79(11):965-71. PubMed ID: 3059235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P
    Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.